| Primary |
| Asthma |
50.0% |
| Sinusitis |
50.0% |
|
| Pharyngeal Oedema |
50.0% |
| Underdose |
50.0% |
|
| Secondary |
| Product Used For Unknown Indication |
33.3% |
| Asthma |
17.3% |
| Polychondritis |
8.0% |
| Psychotic Disorder |
8.0% |
| Restless Legs Syndrome |
6.7% |
| Contraception |
5.3% |
| Cardiac Failure |
4.0% |
| Functional Gastrointestinal Disorder |
2.7% |
| Lung Disorder |
2.7% |
| Plasma Cell Myeloma Recurrent |
2.7% |
| Pneumonia Viral |
2.7% |
| Atrial Fibrillation |
1.3% |
| Cerebrovascular Accident Prophylaxis |
1.3% |
| Drug Toxicity Prophylaxis |
1.3% |
| Hyperlipidaemia |
1.3% |
| Hypertension |
1.3% |
|
| Deep Vein Thrombosis |
15.4% |
| Osteonecrosis |
15.4% |
| Renal Failure Acute |
15.4% |
| Upper Airway Obstruction |
15.4% |
| Respiratory Distress |
7.7% |
| Septic Shock |
7.7% |
| Tendonitis |
7.7% |
| Throat Irritation |
7.7% |
| Twin Pregnancy |
7.7% |
|
| Concomitant |
| Product Used For Unknown Indication |
41.3% |
| Drug Use For Unknown Indication |
16.1% |
| Asthma |
12.3% |
| Prophylaxis |
6.9% |
| Pain |
2.5% |
| Crohn's Disease |
2.3% |
| Decreased Appetite |
2.1% |
| Chronic Obstructive Pulmonary Disease |
2.0% |
| Cancer Pain |
1.7% |
| Insomnia |
1.7% |
| Prostate Cancer |
1.5% |
| Atrial Fibrillation |
1.4% |
| Rheumatoid Arthritis |
1.4% |
| Hypertension |
1.1% |
| Sinusitis |
1.1% |
| Smoking Cessation Therapy |
1.1% |
| Hormone Replacement Therapy |
1.0% |
| Bronchopulmonary Dysplasia |
0.8% |
| Constipation |
0.8% |
| Cough |
0.8% |
|
| Wheezing |
22.0% |
| Dyspnoea |
9.8% |
| Throat Irritation |
6.1% |
| Transfusion Reaction |
6.1% |
| Sleep Disorder |
4.9% |
| Urticaria |
4.9% |
| Vomiting |
4.9% |
| Allergic Granulomatous Angiitis |
3.7% |
| Paraesthesia |
3.7% |
| Radioallergosorbent Test Positive |
3.7% |
| Renal Failure Chronic |
3.7% |
| Respiratory Tract Infection |
3.7% |
| Sepsis |
3.7% |
| Sinusitis |
3.7% |
| Skin Exfoliation |
3.7% |
| Asthma |
2.4% |
| Bronchospasm |
2.4% |
| Decreased Appetite |
2.4% |
| Dysphonia |
2.4% |
| Haemoglobin Decreased |
2.4% |
|
